摘要 假说同时靶向与癌症相关的碳酸酐酶h CA IX和h CA XII亚型(其过表达是癌细胞对缺氧的防御机制)与硫氧还蛋白还原酶(在癌症中过表达以抵抗氧化应激)可能会导致协同增生通过测试两种针对胰腺癌细胞的抑制剂(PANC-1)的组合,证实了这种作用。将两个药效基序组合在一个分子内会导致细胞毒性的急剧增加。这项初步观察为抗癌剂设计的根本新方法奠定了基础。
Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity
作者:Mikhail Krasavin、Tatiana Sharonova、Vladimir Sharoyko、Daniil Zhukovsky、Stanislav Kalinin、Raivis Žalubovskis、Tatiana Tennikova、Claudiu T. Supuran
DOI:10.1080/14756366.2020.1734800
日期:2020.1.1
hCA IX and hCA XII isoforms (whose overexpression is a cancercell’s defence mechanism against hypoxia) along with thioredoxinreductase (overexpressed in cancers as a defence against oxidative stress) may lead to synergistic antiproliferative effects was confirmed by testing combinations of the two inhibitorclassesagainst pancreatic cancercells (PANC-1). Combining both pharmacophoric motifs within
摘要 假说同时靶向与癌症相关的碳酸酐酶h CA IX和h CA XII亚型(其过表达是癌细胞对缺氧的防御机制)与硫氧还蛋白还原酶(在癌症中过表达以抵抗氧化应激)可能会导致协同增生通过测试两种针对胰腺癌细胞的抑制剂(PANC-1)的组合,证实了这种作用。将两个药效基序组合在一个分子内会导致细胞毒性的急剧增加。这项初步观察为抗癌剂设计的根本新方法奠定了基础。